Clinical Trials Directory

Trials / Unknown

UnknownNCT03000049

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University Medicine Greifswald · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock. Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.

Conditions

Interventions

TypeNameDescription
OTHERbedside blood culture

Timeline

Start date
2016-11-01
Primary completion
2017-07-01
Completion
2017-09-01
First posted
2016-12-21
Last updated
2016-12-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03000049. Inclusion in this directory is not an endorsement.